SCHEMBL30689390

SCHEMBL30689390

C=C(Cc1nc(-c2ccc(Oc3ncccc3C)cc2S(C)(=O)=O)no1)C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 1/20 0.37
▸ GSTP1 P09211 6/20 0.37
▸ TP53 P04637 1/20 0.34
▸ FFAR4 Q5NUL3 1/20 0.33
▸ MAPT P10636 3/20 0.33
▸ POLB P06746 1/20 0.33
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ PSMB5 P28074 1/20 0.32
▸ DRD1 P21728 1/20 0.32
▸ TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30689293 0.89 DRD1 (0.38) GSTP1DRD1
SCHEMBL30689425 0.79 MAPT (0.42) PPARGTP53MAPTDRD1TSHR
SCHEMBL31527877 0.77 GSTP1 (0.44) PPARGGSTP1TP53DRD1
SCHEMBL30689426 0.77 CNR2 (0.41) PPARGGSTP1MAPT
SCHEMBL30689373 0.75 PPARG (0.39) PPARGTP53FFAR4MAPTDRD1
SCHEMBL30689352 0.72 PPARG (0.38) PPARGGSTP1TP53MAPT
SCHEMBL31527956 0.71 GSTP1 (0.43) PPARGGSTP1TP53MAPTTSHR
SCHEMBL31527931 0.71 MAPT (0.42) PPARGGSTP1TP53MAPTTSHR
SCHEMBL30689460 0.70 GSTP1 (0.49) PPARGGSTP1TP53MAPTTSHR
SCHEMBL30689444 0.70 SCN7A (0.38) PPARGGSTP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119968366-A Oxadiazole derivatives, methods of preparation and use thereof in the treatment of inflammatory diseases 西特瑞治疗有限公司 2025-05-09 — — CN claimed
CN-119968366-A Oxadiazole derivatives, methods of preparation and use thereof in the treatment of inflammatory diseases 西特瑞治疗有限公司 2025-05-09 — — CN disclosed
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 — — EP disclosed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 — — WO disclosed
Send feedback